Natalia Gorska
Gdansk, PM, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Magnesium level and impulsivity during ketamine administration for treatment-resistant mood disorders.
Journal: Magnesium research
Published: January 23, 2025
Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases.
Journal: Frontiers in psychiatry
Published: May 04, 2021
Copper and Impulsivity in Ketamine Treatment for Treatment-Resistant Mood Disorders.
Journal: Psychiatry and clinical psychopharmacology
Published: April 23, 2021
Magnesium in Ketamine Administration in Treatment-Resistant Depression.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 18, 2021
Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression.
Journal: Brain sciences
Published: October 27, 2020
Copper and anti-anhedonic effect of ketamine in treatment-resistant depression.
Journal: Medical hypotheses
Published: July 06, 2020
Efficacy of Ketamine in bipolar depression: focus on anhedonia.
Journal: Psychiatria Danubina
Published: September 07, 2019
Role of copper and ketamine in major depressive disorder - an update.
Journal: Psychiatria Danubina
Published: September 07, 2019
Suicidality in treatment resistant depression: perspective for ketamine use.
Journal: Psychiatria Danubina
Published: September 07, 2019
Magnesium and ketamine in the treatment of depression.
Journal: Psychiatria Danubina
Published: September 07, 2019
The immunomodulatory effect of ketamine in depression.
Journal: Psychiatria Danubina
Published: September 07, 2019
Antipsychotic drugs in epilepsy.
Journal: Neurologia i neurochirurgia polska
Published: December 07, 2018
Last Updated: 09/26/2026